Document is current
Any future updates will be listed below
-
Authors
Mizuno, Shohei https://orcid.org/0000-0002-4405-8808
Takami, Akiyoshi https://orcid.org/0000-0002-1822-9976
Takamatsu, Hiroyuki
Hanamura, Ichiro
Shimazu, Yutaka
Hangaishi, Akira
Tsukada, Nobuhiro
Kako, Shinichi https://orcid.org/0000-0002-2635-3395
Kikuchi, Taku
Ota, Shuichi https://orcid.org/0000-0002-3631-244X
Shimizu, Hiroaki
Iida, Shinsuke
Yoshioka, Satoshi https://orcid.org/0000-0003-3664-6324
Sawa, Masashi
Fukuda, Takahiro
Kanda, Yoshinobu https://orcid.org/0000-0002-4866-9307
Atsuta, Yoshiko https://orcid.org/0000-0003-4404-2870
Kawamura, Koji
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18ek0510023h0002)
- License Information
-
More Information
Article History
Received: 16 July 2021
Revised: 9 March 2022
Accepted: 11 March 2022
First Online: 24 March 2022
Competing interests
: The authors declare no competing interests.
: This study was designed by the Multiple Myeloma Working Group of the JSTCT and approved by the Transplant Registry Unified Management Program Data Management Committee of the JSTCT and the Institutional Review Board of Aichi Medical University, where the study was conducted. Informed consent was obtained from each patient.
